financetom
Business
financetom
/
Business
/
Apple CEO Tim Cook to meet with Trump on Friday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple CEO Tim Cook to meet with Trump on Friday
Dec 13, 2024 3:45 PM

(Reuters) - Apple ( AAPL ) CEO Tim Cook will meet Donald Trump on Friday night at the U.S. president-elect's Mar-a-Lago resort in Florida, a source familiar with the matter told Reuters.

Business leaders have attempted to establish a positive rapport with Trump since his election win in November.

Meta Platforms and Amazon ( AMZN ) have each donated $1 million to Trump's inaugural fund. Bank of America ( BAC ), the second-largest U.S. lender, also plans to contribute to Trump's inaugural committee but has yet to decide on the amount.

Trump will take office in January. He said in October when he was running for the White House that he received a call from Cook over concerns about the financial penalties that have been imposed by the European Union on the iPhone maker.

European regulators have launched a series of investigations into Big Tech firms in recent years, with the aim of curbing their power and ensuring a level playing field for smaller rivals. A U.S. Justice Department case accuses the iPhone maker of unlawfully dominating the smartphone market.

Trump's team and Apple ( AAPL ) did not immediately respond to a request for comment. The Trump-Cook meeting was reported earlier by the New York Times.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ultragenyx Resubmits FDA Application for Potential Therapy for Rare Neurodegeneration Disease
Ultragenyx Resubmits FDA Application for Potential Therapy for Rare Neurodegeneration Disease
Mar 11, 2026
09:11 AM EST, 01/30/2026 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Friday it has resubmitted its biologics license application for accelerated approval of gene therapy UX111 to treat Sanfilippo syndrome type A to the US Food and Drug Administration. The resubmission follows a complete response letter issued by the FDA in July and includes longer-term data on treatment...
SM ENERGY CLOSES MERGER WITH CIVITAS RESOURCES
SM ENERGY CLOSES MERGER WITH CIVITAS RESOURCES
Mar 11, 2026
Company schedules conference call to discuss fourth quarter and full-year 2025 results and 2026 outlook DENVER, Jan. 30, 2026 /PRNewswire/ -- SM Energy Company ( SM ) (SM Energy ( SM ) or the Company) announced today the closing of its all-stock merger with Civitas Resources, Inc. ( CIVI ) (Civitas) (the Transaction). The Transaction was approved by stockholders of...
McKesson Completes Norway Operations Sale
McKesson Completes Norway Operations Sale
Mar 11, 2026
09:09 AM EST, 01/30/2026 (MT Newswires) -- McKesson (MCK) said Friday it has completed the sale of its retail and distribution businesses in Norway to NorgesGruppen. The transaction marks McKesson's complete exit from its operations in Europe, the company said. ...
Saratoga Investment Prices $100 Million Public Offering of Unsecured Notes
Saratoga Investment Prices $100 Million Public Offering of Unsecured Notes
Mar 11, 2026
09:07 AM EST, 01/30/2026 (MT Newswires) -- Saratoga Investment ( SAR ) said Friday it priced an underwritten public offering of $100 million of 7.50% unsecured notes due 2031. The notes will bear interest at a rate of 7.50% per year, payable quarterly starting May 31. They are expected to be listed on the New York Stock Exchange and to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved